EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Approaches to the Management of Rheumatic Diseases in Pregnancy: Risk Stratification, Therapeutic Advances, and Maternal–Fetal Outcomes

Aikaterini-Gavriela Giannakaki, Maria-Nektaria Giannakaki, Anastasia Bothou, Konstantinos Nikolettos, Nikolaos Machairiotis iD, Kalliopi I Pappa, Panagiotis Tsikouras

Journal of Personalized Medicine · 01.09.2025 · 15 (9) · 406

DOI: 10.3390/jpm15090406 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 01.09.2025. Verfasst von Aikaterini-Gavriela Giannakaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Obstetrics and Gynecology, Alexandra University Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autoimmune rheumatic diseases, including systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), Sjögren’s syndrome, systemic sclerosis (SSc), and rheumatoid arthritis (RA), pose significant challenges during pregnancy and are associated with increased risks of adverse maternal and fetal outcomes, such as preeclampsia, fetal growth restriction (FGR), miscarriage, and preterm birth. The aim of this review is to synthesize recent evidence on pregnancy-related risks, preconception counseling, and therapeutic strategies for these conditions, with a particular focus on the importance of disease remission, pregnancy-compatible medications, and the selective use of biologics.

Methods

A structured narrative review was conducted through a comprehensive PubMed search (2020–2025). Eligible studies addressed maternal–fetal outcomes, therapeutic approaches, and predictive factors in pregnant individuals with autoimmune rheumatic diseases.

Results

Pregnancy outcomes have improved with early disease control and multidisciplinary care; however, major challenges persist. These include limited access to novel therapies, underrepresentation of diverse populations in clinical trials, and insufficient data on long-term neonatal outcomes. The strongest predictors of adverse outcomes remain disease activity at conception, specific autoantibody profiles, and systemic organ involvement.

Conclusions

Optimal pregnancy outcomes for women with autoimmune rheumatic diseases require coordinated multidisciplinary care, the use of pregnancy-compatible medications, and achievement of prolonged disease remission prior to conception. Further research is needed to close existing knowledge gaps and ensure equitable, high-quality maternal–fetal care.

Schlagwörter

Stichwörter der Autor:innen

antiphospholipid syndrome (APS)autoimmune rheumatic diseasematernal–fetal medicinepreconception counselingpregnancy outcomesrisk stratificationsystemic lupus erythematosus (SLE)

Autor:innen und Institutionen

  • First Department of Obstetrics and Gynecology, Alexandra University Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.
  • Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Department of Midwifery, University of West Attica, 12243 Athens, Greece.
  • Department of Gynaecological Oncology, Maidstone and Turnbridge Wells NHS Trust, Maidstone ME169QQ, UK.
  • Third Department of Obstetrics and Gynecology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  • Department of Obstetrics and Gynecology, Democritus University of Thrace, 68100 Alexandroupolis, Greece.

ORCID-Profile: Nikolaos Machairiotis

Zitieren

APA

Giannakaki, A. G., Giannakaki, M. N., Bothou, A., Nikolettos, K., Machairiotis, N., Pappa, K. I., & Tsikouras, P. (2025). Current Approaches to the Management of Rheumatic Diseases in Pregnancy: Risk Stratification, Therapeutic Advances, and Maternal–Fetal Outcomes. Journal of Personalized Medicine, 15(9), 406. https://doi.org/10.3390/jpm15090406

Vancouver

Giannakaki AG, Giannakaki MN, Bothou A, Nikolettos K, Machairiotis N, Pappa KI, et al. Current Approaches to the Management of Rheumatic Diseases in Pregnancy: Risk Stratification, Therapeutic Advances, and Maternal–Fetal Outcomes. Journal of Personalized Medicine. 2025;15(9):406. doi:10.3390/jpm15090406

BibTeX
@article{Giannakaki2025,
  author = {Giannakaki, Aikaterini-Gavriela and Giannakaki, Maria-Nektaria and Bothou, Anastasia and Nikolettos, Konstantinos and Machairiotis, Nikolaos and Pappa, Kalliopi I and Tsikouras, Panagiotis},
  title = {Current Approaches to the Management of Rheumatic Diseases in Pregnancy: Risk Stratification, Therapeutic Advances, and Maternal–Fetal Outcomes},
  journal = {Journal of Personalized Medicine},
  year = {2025},
  volume = {15},
  number = {9},
  pages = {406},
  doi = {10.3390/jpm15090406}
}
Kostenlos starten →